Wilkinson, A.N.; Seely, J.M.; Rushton, M.; Williams, P.; Cordeiro, E.; Allard-Coutu, A.; Look Hong, N.J.; Moideen, N.; Robinson, J.; Renaud, J.;
et al. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. Curr. Oncol. 2023, 30, 7860-7873.
https://doi.org/10.3390/curroncol30090571
AMA Style
Wilkinson AN, Seely JM, Rushton M, Williams P, Cordeiro E, Allard-Coutu A, Look Hong NJ, Moideen N, Robinson J, Renaud J,
et al. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. Current Oncology. 2023; 30(9):7860-7873.
https://doi.org/10.3390/curroncol30090571
Chicago/Turabian Style
Wilkinson, Anna N., Jean M. Seely, Moira Rushton, Phillip Williams, Erin Cordeiro, Alexandra Allard-Coutu, Nicole J. Look Hong, Nikitha Moideen, Jessica Robinson, Julie Renaud,
and et al. 2023. "Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing" Current Oncology 30, no. 9: 7860-7873.
https://doi.org/10.3390/curroncol30090571
APA Style
Wilkinson, A. N., Seely, J. M., Rushton, M., Williams, P., Cordeiro, E., Allard-Coutu, A., Look Hong, N. J., Moideen, N., Robinson, J., Renaud, J., Mainprize, J. G., & Yaffe, M. J.
(2023). Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing. Current Oncology, 30(9), 7860-7873.
https://doi.org/10.3390/curroncol30090571